Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
27
users have liked this narrative
8
users have commented on this narrative
76
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
97
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
FSUN
FirstSun Capital Bancorp
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Southwestern Deposits And Sun Belt Lending Will Fuel Bank Expansion
Key Takeaways Expansion in Southwestern and California markets, paired with strong deposit and loan growth, positions the bank to capitalize on favorable demographic and economic trends. Emphasis on relationship banking, fee-based services, and operational efficiency supports higher non-interest income, improved profitability, and long-term scalable growth.
View narrative
US$43.25
FV
19.1% undervalued
intrinsic discount
10.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Sinclair
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Local News And FCC Moves Will Shape Future Media
Key Takeaways Growth in digital, streaming, and local content initiatives is offsetting TV declines, strengthening Sinclair's revenue base and audience engagement. Regulatory tailwinds and strategic acquisitions are driving operational synergies, revenue diversification, and long-term earnings potential.
View narrative
US$16.21
FV
26.5% undervalued
intrinsic discount
-1.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
BioLife Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Cell And Gene Therapies Will Unlock Biopreservation Potential
Key Takeaways Cross-selling of integrated products and new technology adoption are increasing customer retention and boosting both revenue per dose and overall margins. Strategic acquisitions and a growing regenerative medicine market position BioLife for sustained revenue growth and strengthened market leadership.
View narrative
US$31.10
FV
27.1% undervalued
intrinsic discount
20.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Pebblebrook Hotel Trust
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Urban Hotels And AI Adoption Will Unlock Long-Term Value
Key Takeaways Reinvestment in upgraded assets and adoption of automation technologies are driving higher margins, increased efficiencies, and stronger revenue streams across the portfolio. Major upcoming city events and prudent risk management position the company for substantial urban market growth and resilient long-term earnings.
View narrative
US$11.92
FV
21.0% undervalued
intrinsic discount
2.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Pediatrix Medical Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Rising NICU Demand Will Expand Future Maternal And Neonatal Services
Key Takeaways Growing demand for specialized pediatric and neonatal care, fueled by demographic and policy trends, is supporting recurring revenue and long-term stability. Operational efficiencies and financial flexibility are enabling margin expansion and positioning the company for strategic growth opportunities.
View narrative
US$16.64
FV
13.9% undervalued
intrinsic discount
2.44%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Azenta
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Personalized Medicine And Automation Will Drive Future Market Expansion
Key Takeaways Strong growth driven by personalized medicine, automation, and outsourcing trends, with recurring revenue and margin expansion from stable pricing and digital modernization. Operational efficiency, strategic investments, and disciplined portfolio management are fueling both cost control and sustainable long-term earnings resilience.
View narrative
US$33.00
FV
12.0% undervalued
intrinsic discount
0.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
LUXE
LuxExperience B.V
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Digital Luxury Retail Expansion Will Reshape Affluent Consumer Experiences
Key Takeaways Acquisition of a major luxury retailer and strategic brand partnerships are strengthening LuxExperience's global presence, pricing power, and differentiation. Enhanced focus on exclusive experiences and digital transformation is driving customer loyalty, higher margins, and stable, long-term revenue growth.
View narrative
US$11.40
FV
29.5% undervalued
intrinsic discount
47.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Omnicell
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
OmniSphere Adoption Will Simplify Healthcare Medication Management
Key Takeaways Expansion of SaaS-based recurring revenues and innovative solutions positions Omnicell for sustained growth, margin improvement, and enhanced market differentiation in healthcare automation. Strong demand and a focus on cloud, compliance, and outpatient care enable Omnicell to capture new opportunities despite industry complexity and regulatory challenges.
View narrative
US$44.33
FV
30.5% undervalued
intrinsic discount
3.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
MeridianLink
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Automation And Cloud Lending Will Shape Future Financial Services
Key Takeaways Expanding cloud-based, AI-driven solutions and workflow automation support MeridianLink's recurring revenues, customer retention, and up-sell opportunities. Regulatory complexity and digitization trends drive adoption of MeridianLink's platform, positioning it for sustained growth and increased operational leverage.
View narrative
US$19.08
FV
16.8% undervalued
intrinsic discount
5.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies